FOXM1 and hepatocellular carcinoma: Our data reveal that FVTF inhibits in vitro and in vivo HCC cell stem properties, and FVTF inhibits HCC cell stemness via targeting DNMT1/miR-34a-5p/FoxM1 axis, indicating that FVTF acts as a therapeutic preparation against HCC.